These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 17174141)
1. Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF). Cho JH; Kim HS; Park CS; Kim JK; Jung KY; Shin BK; Kim HK Oral Oncol; 2007 Mar; 43(3):272-7. PubMed ID: 17174141 [TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis. Lim JJ; Kang S; Lee MR; Pai HK; Yoon HJ; Lee JI; Hong SP; Lim CY J Oral Pathol Med; 2003 Oct; 32(9):552-61. PubMed ID: 12969230 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951 [TBL] [Abstract][Full Text] [Related]
5. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis. Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681 [TBL] [Abstract][Full Text] [Related]
6. Maspin in thyroid cancer: its relationship with p53 and clinical outcome. Boltze C; Schneider-Stock R; Meyer F; Peters B; Quednow C; Hoang-Vu C; Roessner A Oncol Rep; 2003; 10(6):1783-7. PubMed ID: 14534696 [TBL] [Abstract][Full Text] [Related]
8. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma. Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598 [TBL] [Abstract][Full Text] [Related]
9. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma. Tanigaki Y; Nagashima Y; Kitamura Y; Matsuda H; Mikami Y; Tsukuda M Int J Mol Med; 2004 Sep; 14(3):389-95. PubMed ID: 15289890 [TBL] [Abstract][Full Text] [Related]
10. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. Kim SH; Cho NH; Kim K; Lee JS; Koo BS; Kim JH; Chang JH; Choi EC J Surg Oncol; 2006 Mar; 93(4):330-7. PubMed ID: 16496371 [TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase expression in various laryngeal lesions in relation to carcinogenesis, angiogenesis, and patients' prognosis. Shigyo H; Nonaka S; Katada A; Bandoh N; Ogino T; Katayama A; Takahara M; Hayashi T; Harabuchi Y Acta Otolaryngol; 2007 Sep; 127(9):970-9. PubMed ID: 17712678 [TBL] [Abstract][Full Text] [Related]
13. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx. Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640 [TBL] [Abstract][Full Text] [Related]
14. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. Linderholm BK; Lindahl T; Holmberg L; Klaar S; Lennerstrand J; Henriksson R; Bergh J Cancer Res; 2001 Mar; 61(5):2256-60. PubMed ID: 11280795 [TBL] [Abstract][Full Text] [Related]
15. [The correlation of vascular endothelial growth factor with angiogenesis and p53 gene in laryngeal squamous cell carcinoma]. Yaylaci A; Cakir S; Güneş P; Akkaynak AC; Naiboğlu B; Gökçeer T Kulak Burun Bogaz Ihtis Derg; 2006; 16(3):105-11. PubMed ID: 16763427 [TBL] [Abstract][Full Text] [Related]
16. Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. Yoshizawa K; Nozaki S; Okamune A; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E J Oral Pathol Med; 2009 Jul; 38(6):535-9. PubMed ID: 19473451 [TBL] [Abstract][Full Text] [Related]
17. Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer. Perrone G; Vincenzi B; Santini D; Verzì A; Tonini G; Vetrani A; Rabitti C Cancer Lett; 2004 May; 208(2):227-34. PubMed ID: 15142682 [TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of SPARC in clinical stage II tongue squamous cell carcinoma. Zhang J; Zhang Q; Zhang Q; Liu XK; Li CQ; Guo ZM Ai Zheng; 2009 Jan; 28(1):68-71. PubMed ID: 19448421 [TBL] [Abstract][Full Text] [Related]
19. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer. Solomon LA; Munkarah AR; Schimp VL; Arabi MH; Morris RT; Nassar H; Ali-Fehmi R Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262 [TBL] [Abstract][Full Text] [Related]
20. Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma. Vered M; Allon I; Dayan D J Oral Pathol Med; 2009 Mar; 38(3):314-20. PubMed ID: 18783348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]